The ASERNIP-S Review Group determined that the evidence base for Autologous Fat Transfer for Breast Augmentation was poor and consequently safety and efficacy could not be determined. The review group further recommended that owing to the lack of evidence regarding patient gain from the procedure of Autologous Fat Transfer for Breast Augmentation, coupled with the theoretical dangers of obscuring carcinoma of the female breast, the ASERNIP-S review group could not endorse the collection of data within Australia for this procedure.